Paper40927629
Nanotechnology-driven advancements in organ transplantation: Multifaceted strategies for organ preservation, ischemia reperfusion injury, immunomodulation and post-transplant monitoring.
Chen Z and 5 others. Mater Today Bio, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Nanotechnology-driven advancements in organ transplantation: Multifaceted strategies for organ preservation, ischemia reperfusion injury, immunomodulation and post-transplant monitoring. Papers, record 40927629. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40927629
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Nanotechnology-driven advancements in organ transplantation: Multifaceted strategies for organ preservation, ischemia reperfusion injury, immunomodulation and post-transplant monitoring.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References106
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35224307 | Adhesive anastomosis for organ transplantation. | Bioact Mater | 2022 | https://conductscience.org/library/papers/35224307 | PubMed |
| 2 | 35100468 | Cerium oxide nanoparticles administration during machine perfusion of discarded human livers: A pilot study. | Liver Transpl | 2022 | https://conductscience.org/library/papers/35100468 | PubMed |
| 3 | 29261332 | Nanomedicine for immunosuppressive therapy: achievements in pre-clinical and clinical research. | Expert Opin Drug Deliv | 2018 | https://conductscience.org/library/papers/29261332 | PubMed |
| 4 | 26936508 | PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. | Sci Transl Med | 2016 | https://conductscience.org/library/papers/26936508 | PubMed |
| 5 | 23578883 | Immunosuppression minimization vs. complete drug withdrawal in liver transplantation. | J Hepatol | 2013 | https://conductscience.org/library/papers/23578883 | PubMed |
| 6 | 31488607 | Deep Learning-Based Histopathologic Assessment of Kidney Tissue. | J Am Soc Nephrol | 2019 | https://conductscience.org/library/papers/31488607 | PubMed |
| 7 | 29398595 | Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond. | EBioMedicine | 2018 | https://conductscience.org/library/papers/29398595 | PubMed |
| 8 | 26167278 | Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity. | RSC Adv | 2015 | https://conductscience.org/library/papers/26167278 | PubMed |
| 9 | 22683850 | Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury. | Transplantation | 2012 | https://conductscience.org/library/papers/22683850 | PubMed |
| 10 | 27682364 | Renal transplant immunology in the last 20 years: A revolution towards graft and patient survival improvement. | Int Rev Immunol | 2017 | https://conductscience.org/library/papers/27682364 | PubMed |
| 11 | 38066781 | Donor-Derived Cell-Free DNA as a Non-Invasive Biomarker for Graft Rejection in Kidney Transplant Recipients: A Prospective Study among the Indian Population. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/38066781 | PubMed |
| 12 | 30413362 | Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance. | Immunity | 2018 | https://conductscience.org/library/papers/30413362 | PubMed |
| 13 | 37431650 | Artificial Urinary Biomarkers for Early Diagnosis of Acute Renal Allograft Rejection. | Angew Chem Int Ed Engl | 2023 | https://conductscience.org/library/papers/37431650 | PubMed |
| 14 | 35422292 | Antibacterial and antioxidant chitosan nanoparticles improve the preservation effect for donor kidneys in vitro. | Carbohydr Polym | 2022 | https://conductscience.org/library/papers/35422292 | PubMed |
| 15 | 21778930 | Targeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death. | Transplantation | 2011 | https://conductscience.org/library/papers/21778930 | PubMed |
| 16 | 35980755 | Co-transplantation of Islets-Laden Microgels and Biodegradable O2-Generating Microspheres for Diabetes Treatment. | ACS Appl Mater Interfaces | 2022 | https://conductscience.org/library/papers/35980755 | PubMed |
| 17 | 34382371 | Vitrification and Nanowarming of Kidneys. | Adv Sci (Weinh) | 2021 | https://conductscience.org/library/papers/34382371 | PubMed |
| 18 | 31836038 | Oxygenation of the Transplanted Kidney. | Semin Nephrol | 2019 | https://conductscience.org/library/papers/31836038 | PubMed |
| 19 | 29187644 | Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys. | Sci Transl Med | 2017 | https://conductscience.org/library/papers/29187644 | PubMed |
| 20 | 37052894 | Noninvasive Early Diagnosis of Allograft Rejection by a Granzyme B Protease Responsive NIR-II Bioimaging Nanosensor. | Angew Chem Int Ed Engl | 2023 | https://conductscience.org/library/papers/37052894 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42719113 | Advances in nanomaterial-based delivery systems for inducing transplantation tolerance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42719113 | PubMed |
| 42141311 | Whole ovary cryopreservation and transplantation: a narrative review of technological advances, biological hurdles, and clinical translation in fertility preservation. | J Assist Reprod Genet | 2026 | https://conductscience.org/library/papers/42141311 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40927629
GET https://conductscience.org/api/papers/v1/40927629/references?page=2